Luque-Paz D, Tattevin P, Loubet P, Benezit F, Thibault V, Laine F
Sci Rep. 2022; 12(1):4199.
PMID: 35273311
PMC: 8913614.
DOI: 10.1038/s41598-022-08089-0.
Yawn B, Suissa S, Rossi A
NPJ Prim Care Respir Med. 2016; 26:16068.
PMID: 27684954
PMC: 5042192.
DOI: 10.1038/npjpcrm.2016.68.
Zhu H, Shi Y, Tang W, Shi G, Wan H
Transl Respir Med. 2016; 1(1):7.
PMID: 27234389
PMC: 6733430.
DOI: 10.1186/2213-0802-1-7.
Chalmers J, Campling J, Dicker A, Woodhead M, Madhava H
BMC Pulm Med. 2016; 16(1):77.
PMID: 27169895
PMC: 4864929.
DOI: 10.1186/s12890-016-0242-0.
Iannella H, Luna C, Waterer G
Ther Adv Respir Dis. 2016; 10(3):235-55.
PMID: 26893311
PMC: 5933605.
DOI: 10.1177/1753465816630208.
Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives.
Cazzola M, Rogliani P, Matera M
Drugs. 2015; 75(14):1575-85.
PMID: 26316169
DOI: 10.1007/s40265-015-0450-6.
Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance.
Earl C, Keong T, An S, Murdoch S, McCarthy Y, Garmendia J
EMBO Mol Med. 2015; 7(8):1018-33.
PMID: 25995336
PMC: 4551341.
DOI: 10.15252/emmm.201505088.
Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function.
Stolberg V, McCubbrey A, Freeman C, Brown J, Crudgington S, Taitano S
J Immunol. 2015; 195(1):174-84.
PMID: 25987742
PMC: 4475455.
DOI: 10.4049/jimmunol.1402217.
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.
Kew K, Seniukovich A
Cochrane Database Syst Rev. 2014; (3):CD010115.
PMID: 24615270
PMC: 8966042.
DOI: 10.1002/14651858.CD010115.pub2.
Experimental rhinovirus infection in COPD: implications for antiviral therapies.
Gunawardana N, Finney L, Johnston S, Mallia P
Antiviral Res. 2013; 102:95-105.
PMID: 24370732
PMC: 7172491.
DOI: 10.1016/j.antiviral.2013.12.006.
Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.
Almirall J, Bolibar I, Serra-Prat M, Palomera E, Roig J, Hospital I
PLoS One. 2013; 8(9):e73271.
PMID: 24039899
PMC: 3764164.
DOI: 10.1371/journal.pone.0073271.
Efferocytosis and lung disease.
McCubbrey A, Curtis J
Chest. 2013; 143(6):1750-1757.
PMID: 23732585
PMC: 3673667.
DOI: 10.1378/chest.12-2413.
Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.
Sibila O, Laserna E, Mortensen E, Anzueto A, Restrepo M
Respir Care. 2013; 58(9):1489-94.
PMID: 23345471
PMC: 4066635.
DOI: 10.4187/respcare.02191.
Glucocorticoids relieve collectin-driven suppression of apoptotic cell uptake in murine alveolar macrophages through downregulation of SIRPα.
McCubbrey A, Sonstein J, Ames T, Freeman C, Curtis J
J Immunol. 2012; 189(1):112-9.
PMID: 22615206
PMC: 3381851.
DOI: 10.4049/jimmunol.1200984.
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: How Significant is the Risk of Pneumonia and Should It Impact Use of Inhaled Corticosteroids?.
Cavallazzi R, Singh S
Curr Infect Dis Rep. 2011; 13(3):296-301.
PMID: 21394429
DOI: 10.1007/s11908-011-0176-x.
